YieldMax MRNA Option Income Strategy ETF (MRNY) price, chart and fund profile
Price chart
Fund profile
MRNY seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options.
- Issuer
- Tidal Investments LLC
- Industry
- —
- Inception
- Oct 23, 2023
- Assets under management
- $132.3M
- Expense ratio
- 0.99%
- Net asset value
- $32.62
- NAV as of
- Aug 28, 2026
- Leverage
- 1×
- Fund page
- yieldmaxetfs.com↗
Frequently asked questions
What is YieldMax MRNA Option Income Strategy ETF (MRNY)?
MRNY seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options.
What is MRNY's expense ratio?
YieldMax MRNA Option Income Strategy ETF charges an annual expense ratio of 0.99%. The fund is issued by Tidal Investments LLC.
How large is MRNY?
YieldMax MRNA Option Income Strategy ETF manages $132.3M in assets and has traded since Oct 23, 2023.
How do I buy shares of YieldMax MRNA Option Income Strategy ETF (MRNY)?
MRNY trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web dashboard at portal.lighthorse.io, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.
Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.